互联网认知行为疗法治疗抑郁的活性成分随机优化试验
该随机优化试验纳入767名抑郁成人,采用32条件平衡部分因子设计检验互联网CBT中7个治疗成分的独立主效应与交互作用。结果显示除吸收训练外,各成分有无对抑郁症状无显著主效应,提示CBT获益可能来自自发缓解、共同因素与非特异性治疗因素。
要点
- 除吸收训练外,各CBT成分有无对抑郁症状无显著主效应。
- 吸收训练在6个月随访时对抑郁症状有显著主效应。
- 互联网CBT总体可降低抑郁症状,但成分特异性效应有限。
核心结论
- 互联网CBT中除吸收训练外,各成分有无对抑郁症状无显著主效应,总体获益可能来自自发缓解、共同因素与非特异性因素。
研究设计与样本
- 采用32条件平衡部分因子优化实验(IMPROVE-2),从互联网广告和英国NHS IAPT服务招募PHQ-9≥10的抑郁成人。
- 共纳入767名参与者,平均年龄38.5岁(SD 11.62,范围18-76),女性635名(82.8%)。
- 参与者以等概率随机分配至7个实验因素的有无条件:活动安排、功能分析、思维挑战、放松、具体性训练、吸收、自我关怀训练。
主要发现
- 接受互联网CBT的参与者平均抑郁症状从治疗前到治疗后PHQ-9评分差值为-7.79(90% CI,-8.21至-7.37)。
- 6个月随访时PHQ-9评分差值为-8.63(90% CI,-9.04至-8.22)。
- 活动安排、功能分析、思维挑战、放松、具体性训练、自我关怀训练的有无对抑郁症状无显著主效应;治疗后最大差值(功能分析)为-0.09(90% CI,-0.56至0.39)。
- 6个月随访最大差值(放松)为-0.18(90% CI,-0.61至0.25)。
- 仅吸收训练在6个月随访时对抑郁症状有显著主效应:治疗后差值为0.21(90% CI,-0.27至0.68),6个月随访差值为-0.54(90% CI,-0.97至-0.11)。
临床怎么用
- 互联网CBT整体可降低抑郁症状,但多数成分的特异性效应不显著。
- 吸收训练可能有助于增强与正强化物的直接接触,可考虑在互联网CBT中保留或强化。
- 临床决策不应仅依赖单一成分的拆分效应,需关注共同因素与非特异性治疗因素。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: There is limited understanding of how complex evidence-based psychological interventions such as cognitive behavioral therapy (CBT) for depression work. Identifying active ingredients may help to make therapy more potent, brief, and scalable. OBJECTIVE: To test the individual main effects and interactions of 7 treatment components within internet-delivered CBT for depression to investigate its active ingredients. DESIGN, SETTING, AND PARTICIPANTS: This randomized optimization trial using a 32-condition, balanced, fractional factorial optimization experiment (IMPROVE-2) recruited adults with depression (Patient Health Questionnaire-9 [PHQ-9] score ≥10) from internet advertising and the UK National Health Service Improving Access to Psychological Therapies service. Participants were randomized from July 7, 2015, to March 29, 2017, with follow-up for 6 months after treatment until December 29, 2017. Data were analyzed from July 2018 to April 2023. INTERVENTIONS: Participants were randomized with equal probability to 7 experimental factors within the internet CBT platform, each reflecting the presence vs absence of specific treatment components (activity scheduling, functional analysis, thought challenging, relaxation, concreteness training, absorption, and self-compassion training). MAIN OUTCOMES AND MEASURES: The primary outcome was depression symptoms (PHQ-9 score). Secondary outcomes include anxiety symptoms and work, home, and social functioning. RESULTS: Among 767 participants (mean age [SD] age, 38.5 [11.62] years; range, 18-76 years; 635 women [82.8%]), 506 (66%) completed the 6-month posttreatment follow-up. On average, participants receiving internet-delivered CBT had reduced depression (pre-to-posttreatment difference in PHQ-9 score, -7.79 [90% CI, -8.21 to -7.37]; 6-month follow-up difference in PHQ-9 score, -8.63 [90% CI, -9.04 to -8.22]). A baseline score-adjusted analysis of covariance model using effect-coded intervention variables (-1 or +1) found no main effect on depression symptoms for the presence vs absence of activity scheduling, functional analysis, thought challenging, relaxation, concreteness training, or self-compassion training (posttreatment: largest difference in PHQ-9 score [functional analysis], -0.09 [90% CI, -0.56 to 0.39]; 6-month follow-up: largest difference in PHQ-9 score [relaxation], -0.18 [90% CI, -0.61 to 0.25]). Only absorption training had a significant main effect on depressive symptoms at 6-month follow-up (posttreatment difference in PHQ-9 score, 0.21 [90% CI, -0.27 to 0.68]; 6-month follow-up difference in PHQ-9 score, -0.54, [90% CI, -0.97 to -0.11]). CONCLUSIONS AND RELEVANCE: In this randomized optimization trial, all components of internet-delivered CBT except absorption training did not significantly reduce depression symptoms relative to their absence despite an overall average reduction in symptoms. The findings suggest that treatment benefit from internet-delivered CBT probably accrues from spontaneous remission, factors common to all CBT components (eg, structure, making active plans), and nonspecific therapy factors (eg, positive expectancy), with the possible exception of absorption focused on enhancing direct contact with positive reinforcers. TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN24117387.
引用
- Watkins E, Newbold A, Tester-Jones M, et al. Investigation of Active Ingredients Within Internet-Delivered Cognitive Behavioral Therapy for Depression: A Randomized Optimization Trial. JAMA Psychiatry. 2023. PMID: 37378962. doi:10.1001/jamapsychiatry.2023.1937
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。